This process involves carnitine palmitoyltransferase 1 (CPT1), which catalyzes the formation of acylcarnitines (CARs) from acyl-CoA esters and free l-carnitine, mitochondrial carnitineacylcarnitine translocase (CACT), responsible for the exchange of a CAR for a free l-carnitine molecule, and carnitine palmitoyltransferase 2 (CPT2), which re-esterifies CARs to acyl-CoA esters within the mitochondrial matrix 1,3,4,5,8
It is not currently an FDA-approved medication, supplement, weight-loss treatment, anti-aging therapy, or performance-enhancing drug
Consultations take place twice a month, with the flexibility of meeting in person or virtually
A recent study by Bayer et al
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy